John A. Jernigan, MD, MS

Director, Office of Prevention Research and Evaluation
Centers for Disease Control and Prevention
Atlanta, Georgia

Disclosure: Nothing to disclose

Presentation(s):

• 837 - Prior Hospitalizations Among Cases of Community-Associated Clostridioides difficile Infection—10 U.S. States, 2014 - 2015

  Thursday, October 3
  1:45 PM – 2:00 PM

• 893 - The SHIELD Orange County Project: A Decolonization Strategy in 35 Hospitals and Nursing Homes Reduces Multi-Drug Resistant Organism (MDRO) Prevalence in a Southern California Region

  Thursday, October 3
  3:15 PM – 3:30 PM

• 1859 - Influential Publications in Public Health and Emerging Pathogens from the Past Year

  Friday, October 4
  4:05 PM – 4:30 PM

• 2850 - Burden of Difficult-to-Treat Antibiotic-Resistant (DTR) Gram-negative Infections in the United States, 2012-2017

  Saturday, October 5
  2:15 PM – 2:30 PM

• 2891 - Trends in Inpatient Antibiotic Use in U.S. Hospitals, 2012-2017

  Saturday, October 5
  3:30 PM – 3:45 PM